Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2023.Jun.16

Announcement on behalf of Obigen of important resolutions of the 2023 annual shareholders’ meeting

2023.Jun.02

The COVID-19 vaccine, BCVax, has been granted by TFDA to proceed to Phase I clinical trial

2023.Jun.02

Announcement of change Spokesperson

2023.Jun.02

Announcement of change of CEO

2023.May.26

Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.

2023.May.26

Announcement on behalf of Obigen to change its financial and accounting officer

2023.May.08

The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)

2023.May.08

The Company’s BOD resolved to amend the plan to disperse shareholding of AP Biosciences (New Shareholding Dispersal Method)

2023.May.08

The Company’s Board of Directors resolved to issue 2023 employee stock options and the subscription rules.

2023.May.08

The Company's Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting (New Approval)

News

Latest News

Events

Latest events